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Abstract
Purpose Characterize ethylbenzene and xylene air con-
centrations, and explore the biological exposure markers
(urinary t,t-muconic acid (t,t-MA) and unmetabolized tol-
uene) among petroleum workers offshore. Offshore work-
ers have increased health risks due to simultaneous
exposures to several hydrocarbons present in crude oil. We
discuss the pooled benzene exposure results from our
previous and current studies and possible co-exposure
interactions.
Methods BTEX air concentrations were measured during
three consecutive 12-h work shifts among 10 tank workers,
15 process operators, and 18 controls. Biological samples
were collected pre-shift on the first day of study and post-
shift on the third day of the study.
Results The geometric mean exposure over the three
work shifts were 0.02 ppm benzene, 0.05 ppm toluene,
0.03 ppm ethylbenzene, and 0.06 ppm xylene. Benzene in
air was significantly correlated with unmetabolized ben-
zene in blood (r = 0.69, p \ 0.001) and urine (r = 0.64,
p \ 0.001), but not with urinary t,t-MA (r = 0.27,
p = 0.20). Toluene in air was highly correlated with the
internal dose of toluene in both blood (r = 0.70,
p \ 0.001) and urine (r = 0.73, p \ 0.001). Co-exposures
were present; however, an interaction of metabolism was
not likely at these low benzene and toluene exposures.
Conclusion Urinary benzene, but not t,t-MA, was a reli-
able biomarker for benzene at low exposure levels. Urinary
toluene was a useful biomarker for toluene exposure.
Xylene and ethylbenzene air levels were low. Dermal
exposure assessment needs to be performed in future
studies among these workers.
Keywords Benzene  Toluene  Xylene  Ethylbenzene 
Biomonitoring  Petroleum workers  Crude oil
Introduction
The aromatic hydrocarbons benzene, toluene, ethylben-
zene, and xylene (collectively labeled: BTEX) are simul-
taneously present in crude oil. While benzene (Group 1)
(IARC 1987) and ethylbenzene (Group 2b) (IARC 2000)
have been classified as carcinogens, the main concern for
exposures to toluene and xylene are their effects on the
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central nervous system. Studies performed in the upstream
petroleum industry have reported wide ranges of volatile
organic hydrocarbon concentrations measured in air (Ver-
ma et al. 2000; Glass et al. 2000; Steinsva˚g et al. 2007;
Bra˚tveit et al. 2007; Runion 1988; Kirkeleit et al. 2006a),
as well as increased risk of cancer types that has been
associated with these hydrocarbons such as leukemia
(Glass et al. 2003; Kirkeleit et al. 2008; Aas et al. 2009),
multiple myeloma (Kirkeleit et al. 2008), malignant mel-
anoma (Lewis et al. 2000; Sorahan et al. 2002; Gun et al.
2004, 2006; Christie et al. 1991; Wong and Raabe 2000),
and kidney cancer (Gun et al. 2006).
Co-exposures to benzene and toluene have been shown
to interact during their metabolism but the degree of
interaction depends on the intensity of exposure. For
example, in a study of factory workers exposed to either
benzene alone (geometric mean (GM) 20 ppm), toluene
alone (GM 38 ppm), or a combination of both (GM 6 and
12 ppm for benzene and toluene, respectively), the urinary
levels of phenol (a metabolite of benzene) and hippuric
acid (a metabolite of toluene) were shown to be signifi-
cantly lower among the co-exposed workers as compared
with the levels in workers who were exposed to either
benzene or toluene alone (Inoue et al. 1988). A recent
study, exposing mice intermittently to low levels of ben-
zene and toluene showed that toluene co-exposure doubled
the genotoxic response (as determined by the erythrocyte
micronucleus test) to benzene alone (Bird et al. 2010).
However, no systematic review of the literature on co-
exposure of these hydrocarbons has been reported, possibly
due to the multiple combinations of co-exposures and
exposure intensities.
The main route of absorption for volatile aromatic
hydrocarbons is by inhalation. However, percutaneous
absorption has been estimated to 0.2–20% of the total
amount absorbed depending on contact time for benzene
(ACGIH 2001) and to 1–2% for toluene (Brooke et al.
1998). Not only liquids, but also vapors may penetrate skin
(Riihimaki and Pfaffli 1978). In workplace situations,
wearing protective suits may even enhance dermal pene-
tration of vapor (Jones et al. 2003). To estimate the internal
dose from all routes of exposure, it is therefore advanta-
geous to use biological monitoring (Lauwerys and Hoet
1993), which also considers the inter-individual variations
in absorption as well as individual variation in metabolism,
excretion, and bioavailability of the chemical agents. The
internal benzene dose can be estimated by several bio-
markers; the most important are unmetabolized benzene in
blood and urine, and the metabolites trans,trans-muconic
acid (t,t-MA) and S-phenylmercapturic acid (SPMA) in
urine (ACGIH 2001). However, the sensitivity and speci-
ficity of these markers have been questioned when expo-
sures are at or below 1 ppm (ACGIH 2001). Biological
monitoring of occupational exposures to toluene is based
on validated urinary biomarkers, such as hippuric acid and
o-creosol for toluene. New biomarkers such as toluene in
urine and S-benzyl-mercaputuric acid (SBMA) for toluene
have been suggested to improve sensitivity and specificity
at low concentrations (ACGIH 2007; Lovreglio et al. 2010;
Ducos et al. 2008). Currently, there is a discrepancy found
in the literature regarding the usefulness of unmetabolized
benzene and toluene as exposure biomarkers especially in
work environments with low exposures.
We have reported that the benzene concentrations in
upstream petroleum workers’ blood and urine were highly
correlated with benzene air concentrations (Kirkeleit et al.
2006b; Bra˚tveit et al. 2007). Adjusting for smoking did not
materially change the results. We also found that the
internal concentrations of benzene appeared higher than
expected considering the measured individual benzene
exposure in air (Kirkeleit et al. 2006b). This could either be
due to co-exposure to other aromatic hydrocarbons, which
may inhibit benzene metabolism (Boogaard and van Sittert
1994; Brondeau et al. 1992; Inoue et al. 1988), greater than
average uptake due to physical exertion, or that especially
benzene, which carries an ACGIH skin notation, may also
enter the body via dermal absorption (ACGIH 2001; Adami
et al. 2006; Carlsson 1982; Nomiyama and Nomiyama
1974). In order to reduce health risks in the upstream
petroleum industry, there is a need for more knowledge
about exposures to hydrocarbons simultaneously present in
crude oil.
This study was part of a study of benzene concentrations
in upstream petroleum workers’ blood and urine (Kirkeleit
et al. 2006b; Bra˚tveit et al. 2007) where exposure levels
and quantitative relationships between benzene in air,
blood, and urine for two groups of workers tank workers
and process operators were presented in two separate
papers (Kirkeleit et al. 2006a, b; Bra˚tveit et al. 2007). We
present here, not previously published, toluene exposure
levels in the working atmosphere and biological media as
well as urinary t,t-MA concentrations. Using the pooled
data set (Kirkeleit et al. 2006b; Bra˚tveit et al. 2007) to
increase the statistical power, we explored the utility of t,t-
MA as a biomarker of benzene exposure and the usefulness
of unmetabolized benzene and toluene biomarkers in this
worker population exposed to low levels of BTEX. Cur-
rently, no exposure measurements have been reported in
the literature regarding exposures to xylene and ethyl
benzene in offshore workers. Here, we present results of a
small pilot study measuring air concentrations of these
components.
We further investigated the possible effects of co-
exposures to petroleum-derived hydrocarbons using tolu-
ene and benzene biomarkers in multiple regression analysis
including smoking as a covariate.
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Our objectives in this study were to:
1. Present air and biological concentrations of toluene
and concentrations of urinary t,t-MA.
2. Evaluate air concentrations of ethylbenzene and
xylene.
3. Explore the utility of t,t-MA as an exposure biomarker
of benzene and the usefulness of unmetabolized
toluene and benzene as biomarkers of toluene and
benzene, respectively, in this worker population.
4. Assess co-exposures of benzene and toluene among
petroleum workers exposed to crude oil.
Methods
Study population
The study population included 43 offshore petroleum
production workers employed on the Norwegian conti-
nental shelf and have been described in detail elsewhere
(Bra˚tveit et al. 2007; Kirkeleit et al. 2006b). Two exposed
groups were identified: ‘‘tank workers’’ (n = 13) who
worked in crude oil cargo tanks were recruited from a
crude oil production vessel where they performed tank
cleaning, tank inspection, scaffold construction, and
welding to mend leaks; and ‘‘process operators’’ (n = 12)
recruited from a fixed oil and gas installation where they
ran the day-to-day operations in the processing area. All
‘‘controls’’ (n = 9 for each exposure group, giving a total
of 18 controls) worked in the living quarters and were
recruited from the same installations and shifts as the
exposed workers. Three of the tank workers did not per-
form their scheduled tank cleaning tasks during the study,
but rather performed tasks typical for the ‘‘process opera-
tors’’. For the purpose of this analysis, we therefore re-
coded these workers from being in the ‘‘tank worker’’
group to ‘‘process operator’’ group due to their similar
exposures with this latter group. The final exposure groups
comprised 10 tank workers, 15 process operators, and 18
controls.
The tank workers generally used a chemical resistant
protective suit during cleaning the tank. Respirators
equipped with organic vapor cartridges were made avail-
able to both process operators and tank workers; however,
we did not record respirator use and change-out schedule,
and thus cannot account for efficiency of protection in our
analyses.
All participants signed an informed written consent and
completed a self-administered questionnaire including a
question on whether they were current smokers (yes/no)
during the study period. The study protocol was approved
by the Western Norway Regional Committee for Medical
Research Ethics and the Data Inspectorate.
Personal air concentrations
The tank workers and process operators were monitored for
personal exposure to BTEX during three consecutive 12-h
work shifts using organic vapor passive dosimetry badges
(3M 3500, St. Paul, MN, USA) as described in Kirkeleit
et al. (2006b) and Bra˚tveit et al. (2007). The arithmetic
mean sampling time for process operators (n = 44) and
tank workers (n = 26) were 647 min (range 379–730) and
608 min (range 224–931), respectively. We did not mea-
sure the personal exposure to benzene for the control
group. BTEX were desorbed in CS2 and analyzed quanti-
tatively and qualitatively by GC/MS (NIOSH NMAM
2003). The level of detection was 0.001 ppm for benzene
and 0.01 ppm for toluene, ethylbenzene, and xylene.
Collection of blood and urine samples
Urine (n = 81) and blood (n = 60) samples used for this
analysis were collected as part of a biomonitoring study on
benzene, which have been described in detail elsewhere
(Kirkeleit et al. 2006b; Bra˚tveit et al. 2007). In short, pre-
shift blood- and urine samples were collected in the morning
before the tank workers entered the tank and for process
operators in the morning at the heliport before departure to
the offshore oil- and gas installation. Post-shift blood- and
urine samples were collected immediately at the end of the
12-h shift on the third day of tank work for tank workers, and
for process operators, immediately after work on the 13th
day, when they were scheduled to return onshore. The post-
shift sample was collected on the third day of the monitoring
of environmental concentrations of BTEX. Control subjects
were monitored for markers of exposure in blood and urine,
and the collection times for the controls were the same as for
the respective exposed participants. Pre-shift blood- and
urine samples were not collected from two process operators
due to late enrollment into the study. As recommended by
the laboratory, blood samples were collected by venipunc-
ture into Venoject II tubes with heparin, while urine
samples were collected in glass bottles (PYREX) with
polypropene stoppers. The samples for analysis of benzene,
toluene, and t,t-MA were stored at 4C in vapor-tight vials
until analysis (maximum 3 months).
Methods for analyzing benzene in blood and urine have
been described previously (Kirkeleit et al. 2006b; Bra˚tveit
et al. 2007) and were similar for the analysis of toluene. In
short, the concentrations of benzene and toluene in blood
were analyzed by a head-space sampler (Perkin Elmer
Headspace sampler HS40, Wellesley, MA, USA) and a gas
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chromatograph (GC) (Perkin Elmer Autosystem) using
photoionization detection according to the method descri-
bed by Pekari et al. (1989, 1992). The samples with ben-
zene or toluene levels at above 5 nmol/l were analyzed by
multi-head space extraction (Ettre and Jones 1984). The
level of quantification was 1 nmol/l, while the ‘‘not
detected level’’ was marked as half of the quantification
limit (0.5 nmol/l).
Urinary benzene and toluene concentrations were ana-
lyzed using GC (Varian Saturn 3400 CX, Varian 8200 CX
autosampler, Palo Alto, CA, USA) and a mass spectrom-
eter (MS) (Varian Saturn 2000). Ions 50?, 77?, and 78?
were selected for quantifying benzene. The quantifications
were based on an internal standard method (chloroben-
zene). The level of quantification was 1 nmol/l, while the
‘‘not detected level’’ was marked as half of the quantifi-
cation limit (0.5 nmol/l).
Muconic acid was separated from the urine sample by
solid phase extraction in an ion exchange column. The
extracted sample was then analyzed by an LC-UV method.
The sample (25 ll) was injected to Agilent 1100 HPLC
system (autosampler, pump unit, degasser, UV detector).
The column used was LiChrosorb RP-8 (200 9 4.6 mm,
particle size 5 lm), the eluent consisted of 18–25%
methanol and 0.1% phosphoric acid (flow 1.0 ml/min), the
detector wavelength was 259 nm, and the retention time for
t,t-MA was about 7 min. The level of quantification was
0.5 lmol/l.
Statistical methods
Distributions of all variables were tested for normality
using the Shapiro–Wilk test. All variables were skewed and
were transformed to their natural logarithm (ln) before
further analysis. All measurements below the limit of
detection (LOD) were replaced with values equal to the
LOD/2 (Hornung and Reed 1990). To account for differ-
ences in urine density between study participants, t,t-MA
was corrected with specific gravity. The specific gravity
should be between 1.010 and 1.030. If specific gravity was
below or above these values, 1.010 and 1.030, respectively,
a correction of 1.024 was used.
For analysis of associations between exposure in the
work environment and concentration of benzene, toluene,
and t,t-MA in biological media, the exposure concentration
measured on the day of sampling the post-shift sample
(third day) was chosen. Correlation studies were carried out
using Sigma plot software on values that had been trans-
formed to their natural logarithm. Correlations between
variables were assessed by Pearson’s r coefficient.
Mixed models analysis of covariance (ANCOVA) was
performed using the PROC MIXED procedure in SAS
version 9.1 (SAS Institute Inc. 2000–2003) to account for
repeated urine measurements collected for each study
participant. We used a backward elimination stepwise
regression analysis to evaluate possible co-exposures.
Covariates and interaction terms that were not statistically
significant (p value [ 0.05) were removed in a stepwise
fashion, beginning with the most complex interaction term.
Both post-shift urinary benzene (models A–C) and post-
shift blood benzene (models D–F) were tested in separate
models (Table 3). Covariates included in all the models
were: job (process operator, tank worker, and control
subjects), age, pre-shift blood/urine benzene values, and
interaction terms. Smoking, a known source of benzene
exposure, was included in all the models. To assess how
random variations and other biomarkers of exposures may
influence the dependent variable (blood or urinary benzene
concentrations), a three-tiered hierarchical approach was
used:
I. The simplest model included the following covariates:
job (process operator, tank worker, and control sub-
jects), age, pre-shift blood/urine benzene values, and
interaction terms; not included were other biomarkers
of benzene (Table 3, model A and D);
II. The random variation model included the covariates as
in the previous model and other biomarkers of
benzene exposures (t,t-MA and blood benzene con-
centrations for the urinary post-shift benzene model
and vice versa) (Table 3, model B and E);
III. The co-exposure model included the covariates as in
the previous model and biomarkers of co-exposure to
toluene (Table 3, model C and F).
To test the possibility of metabolic interaction between
benzene and toluene due to co-exposure, we compared the
regression lines (slopes) of our present observation with the
slopes reported in a study with higher exposure levels;
the study of Waidyanatha et al. (2001) determining urinary
benzene in workers with a median daily exposure of
31 ppm. We regressed urinary benzene post-shift (n = 25)
on benzene air concentrations averaged over 3 days of
sampling. Our controls were not included because we did
not collect benzene air concentrations for this group.
Results
Study population
Most of the workers were men: controls (62.5%), process
operators (66.7%), and tank workers (100%). More than
2/3 of all workers were non-smokers (controls: 29%
smokers, tank workers: 31% smokers, and process opera-
tors: 25% smokers). Tank workers (median age 30.8 years;
range 27.0–55.0) were somewhat younger than both
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controls (median age 45 years; range 29.0–60.0) and pro-
cess operators (median age 44.5 years, range 22.0–59.0).
Environmental exposure to BTEX
Descriptive statistics of BTEX by exposure group (con-
trols, process operators, and tank workers) are presented in
Table 1. The BTEX air concentrations differed between
exposure groups and were significantly different between
process operators and tank workers (mean exposure over
the 3-day study period; benzene p = 0.001, toluene p =
0.001, ethylbenzene p = 0.002, and xylene p \ 0,001).
The benzene air concentration was highly correlated with
the other hydrocarbons; toluene (r = 0.89, p \ 0.001),
ethylbenzene (r = 0.76, p \ 0.001), and xylene (r = 0.90,
p \ 0.001).
Biomarkers of benzene in blood and urine
Descriptive statistics of biomarkers of exposure to benzene
by exposure group (controls, process operators, and tank
workers) and pooled data for the exposed workers are
presented in Table 2. The correlation between benzene
concentration in air third day of study and biological media
post-shift among exposed workers was high both in blood
(r = 0.69, p = 0.0003, n = 22) and urine (r = 0.64,
p = 0.0005, n = 25). The correlation between benzene in
air and urinary t,t-MA post-shift was low and not signifi-
cant (r = 0.27, p = 0.20, n = 25). Benzene concentration
in the air on the third day of study only explained 7% of the
variation in urinary t,t-MA post-shift, while the corre-
sponding percentage for benzene in blood and urine were
48 and 41%, respectively. Adjusting for smoking in mul-
tiple regression analyses did not materially change the
reported correlations. Correlations between post-shift
benzene exposure biomarkers by exposure group and for all
offshore workers combined are shown in Fig. 1. The
strongest correlation was between benzene in blood and
urine, and the weakest for the correlation between blood
benzene and t,t-MA.
Assessment of urinary toluene as an exposure
biomarker for low toluene concentrations
Descriptive statistics of biomarkers of exposure to toluene
by exposure group (controls, process operators, and tank
workers) and pooled data for the exposed workers are pre-
sented in Table 2. Toluene in air showed a good correlation
with the internal dose of toluene in blood (r = 0.70,
p \ 0.001, n = 22) and urine (r = 0.73, p \ 0.001,
n = 25) post-shift among the exposed workers, explaining
49 and 54% of the variation in post-shift blood and urinary
Table 1 Descriptive statistics for BTEX air concentrations by exposure group
Variable Process operators (n = 15) Tank workers (n = 10) Exposed workers (n = 25)
n % [ LOD AM GM GSD n % [ LOD AM GM GSD n % [ LOD AM GM GSD
Benzene (ppm)
Day 1 15 87 0.13 0.01 11.4 8 100 0.30 0.22 2.44 23 91 0.19 0.04 11.1
Day 2 14 79 0.04 0.005 7.66 8 100 0.24 0.16 2.84 22 86 0.12 0.02 10.8
Day 3 15 87 0.01 0.006 3.96 10 100 0.18 0.11 3.29 25 92 0.08 0.02 6.85
All 44 84 0.06 0.01 7.39 26 100 0.23 0.15 2.89 70 90 0.13 0.02 9.26
Toluene (ppm)
Day 1 15 80 0.19 0.04 7.38 8 100 1.61 0.60 3.79 23 87 0.68 0.11 8.93
Day 2 14 71 0.06 0.012 6.07 8 100 0.36 0.26 2.49 22 82 0.17 0.04 7.71
Day 3 15 47 0.02 0.01 3.41 10 100 0.27 0.17 3.06 25 68 0.12 0.03 6.73
All 44 66 0.09 0.02 6.02 26 100 0.71 0.29 3.34 70 79 0.32 0.05 8.09
Ethylbenzene (ppm)
Day 1 15 93 0.07 0.04 3.07 8 100 0.18 0.13 2.43 23 96 0.11 0.06 3.30
Day 2 14 79 0.03 0.02 2.29 8 100 0.13 0.08 2.66 22 86 0.06 0.03 3.08
Day 3 15 87 0.01 0.01 1.65 10 100 0.09 0.06 2.72 25 92 0.04 0.02 2.92
All 44 86 0.04 0.02 2.63 26 100 0.13 0.08 2.68 70 91 0.07 0.03 3.26
Xylene, all isomers (ppm)
Day 1 15 33 0.32 0.02 12.1 8 100 1.02 0.80 2.13 23 57 0.56 0.08 14.5
Day 2 14 43 0.06 0.02 4.78 8 100 0.73 0.50 2.55 22 64 0.30 0.07 7.94
Day 3 15 27 0.02 0.01 2.78 10 100 0.46 0.30 3.05 25 56 0.19 0.04 7.71
All 44 34 0.13 0.02 6.12 26 100 0.72 0.47 2.75 70 67 0.35 0.06 9.67
Int Arch Occup Environ Health (2012) 85:261–271 265
123
toluene, respectively. The correlation between toluene in
blood and urine post-shift was 0.66 (p \ 0.005) (Fig. 1).
Assessment of possible co-exposures
Results from a set of ANOVA models for post-shift urinary
benzene (models A–C) and post-shift blood benzene
(models D–F) are given in Table 3. Both post-shift benzene
biomarkers showed an exposure difference between the
three exposure groups (job) in the simplest models (models
A and D). The final model for urinary benzene post-shift
included job (p value \ 0.0001), pre-shift urinary benzene
(p value = 0.0005), and the interaction term job*pre-shift
urinary benzene (p value = 0.01), while the final model for
blood benzene post-shift included job (p value \ 0.0001),
pre-shift blood benzene (p value = 0.001), and two inter-
action terms: job*smoking (p value = 0.01), and job*pre-
shift blood benzene (p value = 0.01). The second approach
included t,t-MA as a covariate, and this model also showed a
significant difference between jobs; however, it changed the
final models. Urinary benzene post-shift model (B) included
job (p value = 0.009), pre-shift urinary benzene (p value =
0.0002), post-shift blood benzene (p value \ 0.0001), post-
shift t,t-MA (p value = 0.001), and an interaction term
job*pre-shift urinary benzene levels (p value = 0.001); and
the blood benzene post-shift model (E) included job
(p value \ 0.0001), pre-shift blood benzene (p value =
0.001), pre-shift (p value = 0.002) and post-shift urinary
benzene (p value = 0.002), and two interaction terms
(job*smoking (p value = 0.004) and job*pre-shift blood
benzene (p value = 0.003)). Including all biomarkers for
benzene exposures (un-metabolized and metabolized) and
co-exposure biomarkers (models C and F) did not lead to a
significant difference between jobs in the post-shift urinary
benzene model (C), but did show a difference in the post-shift
blood benzene model (F). The final model (F) included job
(p value = 0.001), pre-shift blood benzene (p value = 0.01),
pre-shift urinary t,t-MA (p value = 0.009), pre-shift urinary
toluene (p value = 0.005), and post-shift blood toluene
(p value\ 0.0001). Smoking was not a significant covariate in
the post-shift urinary benzene models, while smoking’s
interaction with job was significant in two post-shift blood
benzene models (D and E).
The relationship between urinary benzene and benzene
air concentrations was strong with a slope of 0.61, which
compares favorably with Waidyanatha et al.’s (2001) slope
estimate of 0.71.
Discussion
BTEX air concentrations were low compared to recom-
mended occupational limits, but were significantly higherT
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in tank workers than in process operators. Urinary benzene,
but not urinary t,t-MA, was a reliable biomarker for ben-
zene exposure. Urinary toluene was a useful biomarker for
toluene exposure at low exposure levels. Few measure-
ments were below the LOD, except for post-shift urinary
benzene levels for controls (Table 2).
Occupational exposure limit values for 8 h of work for
these compounds have been set by the Scientific Com-
mittee on Occupational Exposure Limit (SCOEL) in the
European Union (EU) and the American Conference of
Governmental Industrial Hygienist (ACGIH) and are as
follows: benzene: 0.5 ppm (ACGIH) and 1 ppm (SCOEL),
toluene: 20 ppm (ACGIH) and 50 ppm (SCOEL), xylene:
100 ppm (ACGIH) and 50 ppm (SCOEL), and ethylben-
zene: 100 ppm (ACGIH and SCOEL). Even though our
BTEX air concentrations were low compared to recom-
mended occupational limits, they did differ between
exposure groups and were significantly different between
process operators and tank workers. The reported differ-
ence between the BTEX concentrations in process opera-
tors and tank workers was likely due to the nature of their
tasks; tank workers were directly exposed to crude oil
residues in the tank (Kirkeleit et al. 2006b), while process
operators the majority of their time worked around closed
systems (Bra˚tveit et al. 2007).
Published data on exposure to aromatic hydrocarbons
other than benzene in the petroleum industry are scarce,
probably due to more focus on benzene that is a known
human carcinogen with an exposure limit that is much
lower than the respective limit values for the other aro-
matic hydrocarbons. Most of the studies on the exposure to
these hydrocarbons relevant for the petroleum industry
have been done on service station attendants exposed to
gasoline, where the reported mean exposure range between
0.14 and 1.17 mg/m3 for toluene (Rekhadevi et al. 2010;
Lovreglio et al. 2010; Keretetse et al. 2008; Periago
and Prado 2005) and between 0.22 and 0.96 mg/m3 for
xylene (Rekhadevi et al. 2010; Keretetse et al. 2008;
Periago and Prado 2005). Workers maintaining, repairing,
and inspecting gasoline pumps had a time-weighted aver-
age exposure level of toluene, ethylbenzene, and xylene of
2.2 mg/m3 (0.27–4.3 mg/m3), 0.26 mg/m3 (0.03–0.75 mg/
m3) and 1.1 mg/m3 (0.11–2.47 mg/m3), respectively
(Vainiotalo et al. 2006). Hence, the exposures to toluene,
ethylbenzene, and xylene found among petroleum workers
in the present study were well below occupational exposure
limits, but also lower than what has been reported for other
occupational settings relevant for the petroleum industry.
The level of BTEX measured in air was highly correlated
with each other, which is in agreement with co-exposure of
agents from the petroleum stream.
Occupational exposure studies often involve observa-
tions below the analytical LOD, resulting in left-censored
lognormally distributed data. Substituting the values below
LOD with LOD/2 may introduce bias. The amount of bias
may be highly variable (Ganser and Hewett 2010).
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Fig. 1 Correlations between
biomarkers of exposure (natural
log transformed) for all offshore
workers; process operators and
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tank workers and their controls
(black inverted triangle)
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Maximum likelihood estimates (MLE) have emerged as the
best approach in these cases (Jin et al. 2011); however,
when the dataset deviate substantially from a simple log-
normal distribution as it did in the benzene exposure
dataset of the Australian petroleum industry, the
researchers decided that the LOD/2 method was most
suitable (Glass and Gray 2001).
We have previously reported that the environmental
benzene exposure was highly and significantly correlated
with the post-shift concentration of both benzene in blood
(r = 0.87) and urine (r = 0.90) for the tank workers
(Kirkeleit et al. 2006b) and that these benzene measures
only correlated in the group of process operators when we
adjusted for being a current smoker (Bra˚tveit et al. 2007).
Pooling the two data sets in the present study gave a
somewhat weaker, but still strong, relationship between the
benzene in air in blood (r = 0.69) and urine (r = 0.64).
Correlation coefficients between benzene concentration in
air and benzene in urine post-shift in other studies have
been reported to be 0.38–0.98 (Lovreglio et al. 2010;
Fustinoni et al. 2005; Hakkola and Saarinen 2000).
In contrast to the strong relationship between benzene in
air and the internal dose of parent benzene in blood and
urine, urinary t,t-MA was not correlated with benzene in air.
Numerous studies in the petroleum- or petrochemical
industries have reported that t,t-MA is not a reliable bio-
marker of benzene at exposure levels below 0.1 ppm (Hoet
et al. 2009; Carrieri et al. 2010). Workers exposed to ben-
zene in the same range as the workers in the present study
showed an even lower correlation between environmental
Table 3 Multiple regression models including several biomarkers for the same exposures and co-exposure biomarkers
Model Urinary benzene post-shift models Blood benzene post-shift models
A B C D E F
Incl. Sign* Incl. Sign* Incl. Sign* Incl. Sign* Incl. Sign* Incl. Sign*
Independent variables
Job y * y * y ns y * y * y *
Smoking y ns y ns y ns y ns y ns y ns
Age y ns y ns y ns y ns y ns y ns
Pre-shift urinary benzene y * y * y * n – y * y ns
Pre-shift blood benzene n – y ns y ns y * y * y *
Post-shift urinary benzene dv – dv – dv – y ns y * y ns
Post-shift blood benzene y ns y * y ns dv – dv – dv –
Interactions
Job*Smoking y ns y ns y ns y * y * y ns
Job*Age y ns y ns y ns y ns y ns y ns
Job*Pre-shift blood benzene n – n – n – y * y * y ns
Job*Pre-shift urinary benzene y * y * y ns n – n – n –
Smoking*Age y ns y ns y ns y ns y ns y ns
Smoking*Pre-shift blood benzene n – n – n – y ns y ns y ns
Smoking*Pre-shift urinary benzene y ns y ns y ns n – n – n –
Age*Pre-shift blood benzene n – n – n – y ns y ns y ns
Age*Pre-shift urinary benzene y ns y ns y ns n – n – n –
Job*Age*Smoking y ns y ns y ns y ns y ns y ns
Metabolites included n – y – y – n – y – y –
Pre-shift urinary t,t-MA – – y ns y ns – – y ns y *
Post-shift urinary t,t-MA – – y * y * – – y ns y ns
Co-exposure biomarkers included n – n – y – n n y
Pre-shift urinary toluene – – – – y ns – – – – y *
Pre-shift blood toluene – – – – y ns – – – – y ns
Post-shift urinary toluene – – – – y * – – – – y ns
Post-shift blood toluene – – – – y * – – – – y *
Job (tank worker, process operator, controls), smoking (current, never). Incl independent variable included in the model, Sign* significant, y yes,
n no, dv dependent variable, ns not significant
* Significant at p \ 0.05
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benzene and urinary t,t-MA (Fustinoni et al. 2005). One
possible explanation for the poor correlation between
environmental benzene in air and t,t-MA in urine is that t,t-
MA is also a metabolite of sorbic acid commonly used as a
food additive (Hoet et al. 2009; Negri et al. 2005). We did
not have any information on the use of sorbic acid in the
food served to the workers. Also, although at a higher
exposure level than in the present study, co-exposure to
toluene in rats has been shown to lower t,t-MA exposure in
a concentration-dependent manner (Brondeau et al. 1992).
Biomarker correlations were strong between urinary and
blood benzene as has been shown in other studies (Hoet
et al. 2009). The issue regarding the suitability of t,t-MA as
a biomarker to monitor low exposure to benzene was
apparent for blood benzene correlations with t,t-MA
(Fig. 1). The correlation was weak and non-significant for
low exposed process operators while for tank workers the
correlation was significant, albeit not as good as between
benzene in blood and urine. A lower correlation between t,t-
MA and urinary benzene was also seen in process operators
compared to tank workers. For toluene, the correlations
between the biomarkers did not differ between exposure
groups, showing that both toluene in blood and urine were
reliable biomarkers for low toluene exposures. This has also
been demonstrated by others (Kawai et al. 2008).
Smoking was only significant as an interaction term in
the post-shift blood benzene model, but not in the urinary
benzene models. This could be interpreted as the blood
benzene biomarker being more sensitive to smoking than
the urinary benzene biomarker at low benzene exposures.
Urinary t,t-MA was a significant covariate in the urinary
benzene post-shift model, but not in the blood benzene
post-shift model. This might be explained by the physio-
logical factors of urinary excretion; they will be collected
in the bladder and excreted when the bladder is emptied, or
because the half-life of blood benzene is shorter than in
urine. t,t-MA might not be as sensitive a biomarker as
blood benzene, hence not a significant covariate in this
model (E). Post-shift blood benzene was a significant
covariate for urinary benzene post-shift and vice versa,
showing similar sensitivity at low benzene exposures
(model B and E). Co-exposures are often accounted in
upstream petroleum workers, and toluene may alter the
metabolism of benzene (Bird et al. 2010; Inoue et al. 1988).
Our models including co-exposure biomarkers for toluene
(model C and F) resulted in a non-significant urinary
benzene model; hence, no difference between jobs could be
detected, while post-shift blood benzene could still differ-
entiate between types of jobs. This could indicate that
blood benzene was more sensitive at low exposure than
benzene in urine. Urinary toluene (both post- and pre-
shift), not blood toluene, were significant covariates in this
model. This could indicate a co-exposure result, meaning
that there may be an interaction during metabolism.
However, this must be interpreted with extreme caution for
several reasons: (1) the source for benzene and toluene was
the same (crude oil), thus the significance in the model
could just be an indication of the same source, not an
interaction in metabolism; (2) the toluene and benzene
concentrations were treated as independent covariates in
the model; however, this might not be correct as these
biomarkers were correlated; (3) Could be due to random
variation, which would be more pronounced since our
concentrations are very low and from having few mea-
surements (low statistical power). This is also supported by
the similarity in slopes between workers only exposed to
benzene (Waidyanatha et al. 2001) and our workers. This
indicates that a metabolic interaction between benzene and
toluene due to co-exposures is not likely.
Our results confirm that unmetabolized benzene in urine
is a good biomarker for benzene exposure and can be used
in biological monitoring of benzene at exposure levels
below 1 ppm. Our results give further support to the argu-
ment for not using t,t-MA as an internal dose biomarker for
benzene exposures at these low air concentration levels. A
limitation with our study is that we did not evaluate other
exposure biomarkers for benzene such as urinary S-phe-
nylmercapturic acid and for toluene such as hippuric acid,
o-creosol, and S-benzyl-mercaputuric acid. We were not
able to include gender as a covariate in our analysis because
the tank workers were all men. Excluding the tank workers
from the multiple regression analysis and including only
controls and low exposed process operators would not give
a representative picture of possible gender differences.
Conclusions
Urinary benzene, not t,t-MA, should be used as a bio-
marker of benzene in the petroleum industry. Urinary tol-
uene was a useful biomarker for toluene exposure. Our
study shows that urine sampling is an efficient and very
reliable way of assessing exposure to benzene and toluene
in petroleum workers with low exposure and co-exposures
to a range of petroleum-derived hydrocarbons. A better
understanding of the work performed in upstream petro-
leum industry including dermal exposures, co-exposures,
and use of personal protective equipment may lead to better
exposure assessments in epidemiological studies and con-
sequently our understanding of the increased risk of some
cancer types reported among workers in this industry.
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